Saltar al contenido
Merck

Novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase.

Bioorganic & medicinal chemistry letters (2010-08-31)
Joris W De Schutter, Serge Zaretsky, Sarah Welbourn, Arnim Pause, Youla S Tsantrizos
RESUMEN

A structure-based approach was pursued in designing novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase (hFPPS). Preliminary SAR and structural evidence for the simultaneous binding of these inhibitors into the isopentenyl pyrophosphate (IPP) and the geranyl pyrophosphate (GPP) substrate sub-pockets of the enzyme are presented.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Geranyl pyrophosphate ammonium salt, 1 mg/mL in methanol (:aqueous 10 mM NH4OH (7:3)), ≥95% (TLC)
Sigma-Aldrich
Geranyl pyrophosphate lithium salt, ≥95.0% (TLC)
Supelco
Geranyl pyrophosphate lithium salt, analytical standard